A proactive, interdisciplinary approach is essential to effectively manage the evolving challenges associated with 505(b)(2) medications. Implementing structured tools, including a crosswalk comparison tool, directory, and prioritization matrix, provided a systematic method to identify and monitor these products within a complex regulatory environment. Continued refinement will be necessary as CMS and Food and Drug Administration policies evolve, but this model offers a framework that may be adapted to different care settings.
Building similarity graph...
Analyzing shared references across papers
Loading...
Matsuda et al. (Thu,) studied this question.
synapsesocial.com/papers/69ada885bc08abd80d5bb867 — DOI: https://doi.org/10.1093/ajhp/zxag063
Chloe Matsuda
Russell Findlay
Utah Department of Health
Erin R. Fox
American Journal of Health-System Pharmacy
Utah Department of Health
Building similarity graph...
Analyzing shared references across papers
Loading...